TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

Part of paid clinical trials in Laguna Hills, California.

Sponsor
Linda Chan, MD
Study ID
NCT04552509
Status
Recruiting

Conditions

Eligibility Criteria

Sex
MALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Stereotactic Body Radiotherapy — RADIATION
    Treatment of prostate cancer with stereotactic body radiation therapy (SBRT)

Study Details

The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of this evaluation is to see if this treatment will help patients with your condition and to evaluate the effect of this treatment on your quality of life over time. Radiosurgery is a non-invasive treatment technique used to treat tumors. Despite the word "surgery" in the name, the technology does not remove the tumor with a surgical knife. Instead, a focused, high-intensity beam of radiation targets the tumor, while minimizing dose to surrounding normal healthy tissue.

Key Dates

Start date
Jun 5, 2018
Status verified
May 2025
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
167 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Observation
    Observational study of patient efficacy and side effects

Primary Outcome Measure

Local control [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MemorialCare Saddleback Medical CenterLaguna HillsCalifornia92653
Linda Chan, MD
562-933-0300

Find similar trials in Laguna Hills, CA

By condition

Related Studies